Eight-Year Outcomes of Testosterone Suppression plus Enzalutamide or a Non-Steroidal Anti-Androge... https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/172041-eight-year-outcomes-of-testosterone-suppression-plus-enzalutamide-or-a-non-steroidal-anti-androgen-for-metastatic-hormone-sensitive-prostate-cancer-enzamet-anzup-1304-beyond-the-abstract.html?utm_source=newsletter_15990&utm_medium=email&utm_campaign=uroalerts-prostate-cancer-weeklyImpressive results from ENZAMET, now including OS.